Recombinant TACSTD2 antibody (AA 31-274)
Quick Overview for Recombinant TACSTD2 antibody (AA 31-274) (ABIN7477593)
Target
See all TACSTD2 AntibodiesAntibody Type
Reactivity
Host
Clonality
Conjugate
Application
Clone
-
-
Binding Specificity
- AA 31-274
-
Immunogen
- Recombinant fragment of human TACSTD2 protein (around aa 31-274) (exact sequence is proprietary)
-
Isotype
- IgG
-
-
-
-
Application Notes
- IHC 1:100-1:200
-
Comment
-
Positive Control: Liver: A strong membranous Trop-2 immunostaining should be seen in bile ducts.
Negative Control: Liver: Hepatocytes should not show any Trop-2 immunostaining.
-
Protocol
- Manual Protocol: Freshly cut sections should be used (less than 10 days between cutting and staining). Heat-induced antigen retrieval for 5 minutes in an autoclave at 121 °C in pH 7,8 Target Retrieval Solution buffer. Apply the antibody at a dilution of 1:150 at 37 °C for 60 minutes. Visualization of bound antibody by the EnVision Kit (Dako, Agilent) according to the manufacturer's directions.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Storage
- 4 °C,-20 °C,-80 °C
-
Storage Comment
- Antibody with azide - store at 2 to 8 °C. Antibody without azide - store at -20 to -80 °C. Antibody is stable for 24 months. Non- hazardous.
-
-
- TACSTD2 (Tumor-Associated Calcium Signal Transducer 2 (TACSTD2))
-
Alternative Name
- TACSTD2 / Trop-2
-
Background
- Cell surface glycoprotein Trop-2, Membrane Component Chromosome 1, Surface Marker 1 (M1S1), Pancreatic Carcinoma Marker Protein GA733-1, TROP2, Tumor-Associated Calcium Signal Transducer 2 (TACSTD2),TACSTD2 / Trop-2 antibody validated for immunohistochemistry on 76 different Normal Tissues
-
UniProt
- P09758
Target
-